IRONWOOD PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Ironwood Pharmaceuticals Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Ironwood Pharmaceuticals Inc Other Assets, Noncurrent for the quarter ending June 30, 2024 was $4.26M, a 8.6% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.26M +$337K +8.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.4M +$2.58M +314% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.61M +$2.76M +326% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $3.82M +$2.96M +343% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.92M +$3.05M +350% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $820K -$135K -14.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $847K -$153K -15.3% Dec 31, 2022 10-K 2024-02-16
Q3 2022 $863K +$8K +0.94% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $872K -$7K -0.8% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $955K +$31K +3.36% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $1M +$57K +6.05% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $855K -$26K -2.95% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $879K +$59K +7.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $924K +$86K +10.3% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $943K +$153K +19.4% Dec 31, 2020 10-K 2022-02-18
Q3 2020 $881K +$861K +4305% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $820K +$794K +3054% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $838K +$782K +1396% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $790K +$701K +788% Dec 31, 2019 10-K 2021-02-17
Q3 2019 $20K -$688K -97.2% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $26K -$745K -96.6% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 $56K -$753K -93.1% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $89K -$781K -89.8% Dec 31, 2018 10-K 2020-02-13
Q3 2018 $708K -$91K -11.4% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $771K +$33K +4.47% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 $809K +$26K +3.32% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $870K -$586K -40.2% Dec 31, 2017 10-K 2019-02-25
Q3 2017 $799K -$613K -43.4% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $738K -$1.08M -59.4% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $783K -$1.46M -65.1% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $1.46M -$1.17M -44.6% Dec 31, 2016 10-K 2018-02-22
Q3 2016 $1.41M -$1.81M -56.2% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $1.82M -$1.69M -48.1% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $2.24M -$3.79M -62.8% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $2.63M -$414K -13.6% Dec 31, 2015 10-K 2017-02-22
Q3 2015 $3.22M -$302K -8.57% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $3.5M -$93K -2.59% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $6.03M +$2.13M +54.8% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $3.04M -$1.27M -29.4% Dec 31, 2014 10-K 2016-02-19
Q3 2014 $3.53M -$1.11M -24% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $3.6M -$1.49M -29.3% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $3.9M -$1.32M -25.3% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 $4.31M +$4.03M +1423% Dec 31, 2013 10-K 2015-02-18
Q3 2013 $4.64M +$4.59M +8491% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 $5.09M +$5.02M +6780% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $5.21M +$5.09M +4103% Mar 31, 2013 10-Q 2013-04-23
Q4 2012 $283K +$145K +105% Dec 31, 2012 10-K 2014-02-07
Q3 2012 $54K -$138K -71.9% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $74K -$140K -65.4% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $124K Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $138K -$136K -49.6% Dec 31, 2011 10-K 2013-02-21
Q3 2011 $192K Sep 30, 2011 10-Q 2011-11-09
Q2 2011 $214K Jun 30, 2011 10-Q 2011-08-12
Q4 2010 $274K Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.